Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis

Archive ouverte

Steyn, Frederik | Li, Rui | Kirk, Siobhan | Tefera, Tesfaye | Xie, Teresa | Tracey, Timothy | Kelk, Dean | Wimberger, Elyse | Garton, Fleur | Roberts, Llion | Chapman, Sarah | Coombes, Jeff | Leevy, W Matthew | Ferri, Alberto | Valle, Cristiana | René, Frédérique | Loeffler, Jean-Philippe | Mccombe, Pamela | Henderson, Robert | Ngo, Shyuan

Edité par CCSD ; Oxford University Press on behalf of the Guarantors of Brain -

International audience. Abstract Amyotrophic lateral sclerosis is characterized by the degeneration of upper and lower motor neurons, yet an increasing number of studies in both mouse models and patients with amyotrophic lateral sclerosis suggest that altered metabolic homeostasis is also a feature of disease. Pre-clinical and clinical studies have shown that modulation of energy balance can be beneficial in amyotrophic lateral sclerosis. However, the capacity to target specific metabolic pathways or mechanisms requires detailed understanding of metabolic dysregulation in amyotrophic lateral sclerosis. Here, using the SOD1G93A mouse model of amyotrophic lateral sclerosis, we demonstrate that an increase in whole-body metabolism occurs at a time when glycolytic muscle exhibits an increased dependence on fatty acid oxidation. Using myotubes derived from muscle of amyotrophic lateral sclerosis patients, we also show that increased dependence on fatty acid oxidation is associated with increased whole-body energy expenditure. In the present study, increased fatty acid oxidation was associated with slower disease progression. However, within the patient cohort there was considerable heterogeneity in whole-body metabolism and fuel oxidation profiles. Thus, future studies that decipher specific metabolic changes at an individual patient level are essential for the development of treatments that aim to target metabolic pathways in amyotrophic lateral sclerosis.

Suggestions

Du même auteur

Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

Archive ouverte | Hop, Paul | CCSD

International audience. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with an estimated heritability between 40 and 50%. DNA methylation patterns can serve as proxies of (past) exposures a...

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Archive ouverte | van Rheenen, Wouter | CCSD

International audience. Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk of one in 350 people and an unmet need for disease-modifying therapies. We conducted a c...

Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?

Archive ouverte | Quessada, Cyril | CCSD

International audience. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive and selective loss of motor neurons, amyotrophy and skeletal muscle paralysis usually lea...

Chargement des enrichissements...